Structures by: Glidewell C.
Total: 1 449
Morpholin-4-ium 4-amino-2-(morpholin-4-yl)-5-nitroso-6-oxo-1,6-dihydropyrimidin-1-ide
C4H10NO,C8H10N5O3
Acta Crystallographica Section C (2008) 64, 4 o220-o225
a=9.4410(11)Å b=16.347(4)Å c=18.799(5)Å
α=90.00° β=90.045(15)° γ=90.00°
Ethyl 2-methoxy-6-[(triphenylphosphoranylidene)amino]nicotinate
C27H25N2O3P
Acta Crystallographica Section C (2008) 64, 4 o233-o236
a=8.5336(18)Å b=11.063(3)Å c=13.426(3)Å
α=73.722(18)° β=72.389(16)° γ=85.93(2)°
Ethyl 2-methylsulfanyl-6-[(triphenylphosphoranylidene)amino]nicotinate
C27H25N2O2PS
Acta Crystallographica Section C (2008) 64, 4 o233-o236
a=8.5671(14)Å b=11.0617(6)Å c=13.547(2)Å
α=102.987(8)° β=106.417(12)° γ=94.596(10)°
2-(<i>tert</i>-Butylamino)-4-chloro-6-ethylamino-1,3,5-triazine
C9H16ClN5
Acta Crystallographica Section C (2008) 64, 8 o463-o466
a=23.557(3)Å b=9.9789(15)Å c=20.3594(17)Å
α=90.00° β=90.00° γ=90.00°
(2SR,4RS)-7-Chloro-2-<i>exo</i>-[(<i>E</i>)-styryl]-2,3,4,5-tetrahydro- 1,4-epoxy-1H-1-benzazepine
C18H16ClNO
Acta Crystallographica Section C (2008) 64, 9 o514-o518
a=10.5798(8)Å b=5.3448(10)Å c=12.873(3)Å
α=90.00° β=90.204(12)° γ=90.00°
(2RS,4RS)-7-Chloro-2-<i>endo</i>-[(<i>E</i>)-styryl]-2,3,4,5-tetrahydro- 1,4-epoxy-1H-1-benzazepine
C18H16ClNO
Acta Crystallographica Section C (2008) 64, 9 o514-o518
a=5.2855(10)Å b=15.649(2)Å c=17.880(3)Å
α=90.00° β=90.00° γ=90.00°
(2<i>R</i>,4<i>R</i>)-7-fluoro-2-endo-[(<i>E</i>)-styryl]-2,3,4,5-tetrahydro- 1,4-epoxy-1H-1-benzazepine
C18H16FNO
Acta Crystallographica Section C (2008) 64, 9 o514-o518
a=5.4172(2)Å b=8.0164(6)Å c=16.2310(11)Å
α=90.00° β=96.745(4)° γ=90.00°
(2<i>S</i>,4<i>R</i>)-2-<i>exo</i>-(5-bromo-2-thienyl)-7-trifluoromethoxy- 2,3,4,5-tetrahydro-1H-1,4-epoxy-1-benzazepine
C15H11BrF3NO2S
Acta Crystallographica Section C (2008) 64, 9 o524-o528
a=5.6913(6)Å b=10.1187(6)Å c=13.2996(13)Å
α=90.00° β=100.497(8)° γ=90.00°
(2<i>S</i>,4<i>R</i>)-7-chloro-2-<i>exo</i>-(2-chlorophenyl)- 2,3,4,5-tetrahydro-1H-1,4-epoxy-1-benzazepine
C16H13Cl2NO
Acta Crystallographica Section C (2008) 64, 9 o519-o523
a=7.4328(11)Å b=12.3746(16)Å c=14.9187(19)Å
α=90.00° β=90.00° γ=90.00°
(2<i>S</i>,4<i>R</i>)-7-chloro-2-<i>exo</i>- (1-naphthyl)-2,3,4,5-tetrahydro-1H-1,4-epoxy-1-benzazepine
C20H16ClNO
Acta Crystallographica Section C (2008) 64, 9 o519-o523
a=9.6174(18)Å b=11.558(3)Å c=13.465(4)Å
α=90.00° β=90.00° γ=90.00°
2-<i>tert</i>-Butyl-5-methyl-7,8-dihydro-6<i>H</i>- cyclopenta[<i>e</i>]pyrazolo[1,5-<i>a</i>]pyrimidine
C14H19N3
Acta Crystallographica Section C (2008) 64, 9 o471-o473
a=6.8665(6)Å b=9.4084(14)Å c=11.147(2)Å
α=91.611(14)° β=107.728(14)° γ=111.097(12)°
9-Benzoyl-3,3,6,6-tetramethyl-1,2,3,4,5,6,7,8-octahydroxanthene-1,8-dione
C24H26O4
Acta Crystallographica Section C (2008) 64, 10 o554-o557
a=11.6394(15)Å b=11.5736(15)Å c=30.782(4)Å
α=90.00° β=90.00° γ=90.00°
Trans-Tetraaquadichloridocobalt(II)--piperazine-2,5-dione (1/1)
Cl2CoH8O4,C4H6N2O2
Acta Crystallographica Section C (2008) 64, 8 m286-m291
a=9.5326(4)Å b=6.6602(2)Å c=10.0167(4)Å
α=90.00° β=114.1660(17)° γ=90.00°
Silver(I) nitrate--piperazine-2.5-dione (1/1)
C8H12Ag2N6O10
Acta Crystallographica Section C (2008) 64, 8 m286-m291
a=9.62760(10)Å b=14.7180(2)Å c=5.2468(4)Å
α=90.00° β=90.00° γ=90.00°
<i>catena</i>-poly[[[<i>trans</i>-diaquacopper(II)]-di-μ-chlorido] piperazine-2,5-dione solvate]
Cl2CuH4O2,2C2H3NO
Acta Crystallographica Section C (2008) 64, 8 m286-m291
a=15.224(3)Å b=3.9694(8)Å c=15.444(4)Å
α=90.00° β=94.73(3)° γ=90.00°
(2SR,4RS)-2-<i>exo</i>-(5-bromo-2-thienyl)-7-fluoro- 2,3,4,5-tetrahydro-1H-1,4-epoxy-1-benzazepine
C14H11BrFNOS
Acta Crystallographica Section C (2008) 64, 9 o524-o528
a=8.1835(6)Å b=10.9447(8)Å c=14.6940(12)Å
α=90.00° β=104.969(6)° γ=90.00°
(2SR,4RS)-7-Fluoro-2-<i>exo</i>-(2-furyl)-2,3,4,5-tetrahydro-1H-1,4-epoxy- 1-benzazepine
C14H12FNO2
Acta Crystallographica Section C (2008) 64, 9 o524-o528
a=5.5314(10)Å b=15.430(4)Å c=26.229(6)Å
α=90.00° β=92.960(17)° γ=90.00°
Hexamethylenediammonium bis(chloroacetate)
C6H18N22,2C2H2ClO2
Acta Crystallographica Section C (2008) 64, 9 o505-o507
a=6.5779(18)Å b=7.3593(10)Å c=8.425(2)Å
α=97.277(12)° β=95.631(15)° γ=111.037(12)°
(2SR,4RS)-7-chloro-2-<i>exo</i>-(4-chlorophenyl)-2,3,4,5-tetrahydro- 1H-1,4-epoxy-1-benzazepine
C16H13Cl2NO
Acta Crystallographica Section C (2008) 64, 9 o519-o523
a=11.9348(11)Å b=21.617(2)Å c=5.3024(6)Å
α=90.00° β=90.00° γ=90.00°
2-Amino-4-chloro-5-formyl-6-[methyl(2-methylphenyl)amino]pyrimidine
C13H13ClN4O
Acta Crystallographica Section C (2009) 65, 1 o11-o14
a=11.1502(8)Å b=8.7271(8)Å c=13.7129(13)Å
α=90.00° β=105.676(7)° γ=90.00°
2-amino-4-chloro-5-formyl-6-[(2-methoxyphenyl)methylamino]pyrimidine,
C13H13ClN4O2
Acta Crystallographica Section C (2009) 65, 1 o11-o14
a=11.301(4)Å b=8.642(3)Å c=14.568(5)Å
α=90.00° β=111.13(3)° γ=90.00°
(2<i>S</i>,4<i>R</i>)-8-Chloro-9-methyl-2-<i>exo</i>-(1-naphthyl)-2,3,4,5- tetrahydro-1<i>H</i>-1,4-epoxy-1-benzazepine
C21H18ClNO
Acta Crystallographica Section C (2010) 66, 11 o540-o546
a=7.4394(7)Å b=14.498(3)Å c=15.136(3)Å
α=90.00° β=90.00° γ=90.00°
2-Cyano-<i>N</i>-(4,6-dimethoxypyrimidin-2-yl)acetamide
C9H10N4O3
Acta Crystallographica Section C (2010) 66, 10 o521-o523
a=4.1760(6)Å b=11.296(2)Å c=12.070(3)Å
α=116.929(15)° β=90.478(13)° γ=95.767(15)°
1-(2-Aminophenyl)-3-(4-pyridyl)prop-2-en-1-one
C14H12N2O1
Acta Crystallographica Section C (2010) 66, 12 o589-o592
a=27.922(6)Å b=6.4261(8)Å c=14.668(3)Å
α=90.00° β=118.849(18)° γ=90.00°
(2<i>SR</i>,4<i>RS</i>)-7-Methyl-2-<i>exo</i>-(1-naphthyl)-2,3,4,5-tetrahydro- 1<i>H</i>-1,4-epoxy-1-benzazepine
C21H19NO
Acta Crystallographica Section C (2010) 66, 11 o540-o546
a=10.7760(13)Å b=8.9612(11)Å c=15.4241(15)Å
α=90.00° β=96.799(10)° γ=90.00°
10-Benzyl-4-oxo-2,3,4,10-tetrahydropyrimido[4,5-<i>b</i>]quinolin-2-iminium chloride sesquihydrate
C18H15N4O,Cl,1.5(H2O)
Acta Crystallographica Section C (2010) 66, 9 o469-o472
a=18.8725(10)Å b=18.4777(8)Å c=13.417(2)Å
α=90.00° β=134.307(7)° γ=90.00°
3-<i>tert</i>-butyl-1-(4-chlorophenyl)-4- phenylindeno[1,2-<i>b</i>]pyrazolo[4,3-<i>e</i>]pyridin-5(1<i>H</i>)-one
C29H22ClN3O
Acta Crystallographica Section C (2011) 67, 12 o479-o483
a=8.1014(5)Å b=11.3554(10)Å c=13.5762(11)Å
α=102.755(7)° β=90.013(8)° γ=108.268(7)°
3-<i>tert</i>-butyl-1-(4-chlorophenyl)-4- (4-methoxyphenyl)indeno[1,2-<i>b</i>]pyrazolo[4,3-<i>e</i>]pyridin-\ 5(1<i>H</i>)-one
C30H24ClN3O2
Acta Crystallographica Section C (2011) 67, 12 o479-o483
a=11.1911(9)Å b=11.4258(8)Å c=20.095(2)Å
α=97.411(6)° β=93.272(7)° γ=107.635(6)°
6-Chloro-3-methyl-1,4-diphenylpyrazolo[3,4-<i>b</i>]pyridine-5-carbaldehyde
C20H14ClN3O
Acta Crystallographica Section C (2012) 68, 1 o12-o18
a=16.784(3)Å b=9.6380(8)Å c=21.699(4)Å
α=90.00° β=108.820(12)° γ=90.00°
6-Chloro-3-methyl-4-(4-methylphenyl)-1-phenyl- pyrazolo[3,4-<i>b</i>]pyridine-5-carbaldehyde
C21H16ClN3O
Acta Crystallographica Section C (2012) 68, 1 o12-o18
a=8.2898(8)Å b=9.9191(14)Å c=10.3666(10)Å
α=87.108(11)° β=86.808(8)° γ=85.088(12)°
6-Chloro-4-(4-chlorophenyl)-3-methyl-1- phenylpyrazolo[3,4-<i>b</i>]pyridine-5-carbaldehyde
C20H13Cl2N3O
Acta Crystallographica Section C (2012) 68, 1 o12-o18
a=20.868(3)Å b=9.603(4)Å c=16.924(9)Å
α=90.00° β=90.00° γ=90.00°
4-(4-bromophenyl)-6-chloro-3-methyl-1- phenylpyrazolo[3,4-<i>b</i>]pyridine-5-carbaldehyde
C20H13BrClN3O
Acta Crystallographica Section C (2012) 68, 1 o12-o18
a=9.3826(11)Å b=9.7781(12)Å c=10.1072(6)Å
α=108.077(10)° β=99.353(9)° γ=90.911(10)°
6-Chloro-4-(4-methoxyphenyl)-3-methyl-1- phenylpyrazolo[3,4-<i>b</i>]pyridine-5-carbaldehyde
C21H16ClN3O2
Acta Crystallographica Section C (2012) 68, 1 o12-o18
a=8.6972(8)Å b=10.039(2)Å c=10.090(2)Å
α=85.23(2)° β=80.856(16)° γ=86.665(16)°
6-Chloro-3-methyl-4-(4-nitrophenyl)-1- phenylpyrazolo[3,4-<i>b</i>]pyridine-5-carbaldehyde
C20H13ClN4O3
Acta Crystallographica Section C (2012) 68, 1 o12-o18
a=11.7839(13)Å b=9.9890(4)Å c=15.71(2)Å
α=90.00° β=106.084(8)° γ=90.00°
2-Amino-6-methoxy-4-(4-methylanilino)-5-nitrosopyrimidine
C12H13N5O2
Acta Crystallographica Section C (2012) 68, 5 o199-o203
a=6.975(2)Å b=7.4704(10)Å c=12.161(4)Å
α=102.90(2)° β=92.64(3)° γ=101.144(19)°
7-bromo-2-<i>exo</i>-(2-chlorophenyl)-2,3,4,5-tetrahydro- 1,4-epoxynaphtho[1,2-<i>b</i>]azepine
C20H15BrClNO
Acta Crystallographica Section C (2012) 68, 3 o123-o125
a=11.5083(8)Å b=8.1027(6)Å c=18.3210(16)Å
α=90.00° β=110.505(5)° γ=90.00°
2-<i>exo</i>-(5-nitrofuran-2-yl)-2,3,4,5-tetrahydro-1,4-epoxy- 1<i>H</i>-1-benzazepine
C14H12N2O4
Acta Crystallographica Section C (2012) 68, 3 o131-o140
a=7.2248(5)Å b=18.1447(19)Å c=9.4504(8)Å
α=90.00° β=94.279(6)° γ=90.00°
7-fluoro-2-<i>exo</i>-(5-methylfuran-2-yl)-2,3,4,5-tetrahydro-1,4-epoxy- 1<i>H</i>-1-benzazepine
C15H14FNO2
Acta Crystallographica Section C (2012) 68, 3 o131-o140
a=5.5265(5)Å b=10.6652(19)Å c=20.905(4)Å
α=90.00° β=97.166(11)° γ=90.00°
7-fluoro-2-<i>exo</i>-(3-methylthiophen-2-yl)-2,3,4,5-tetrahydro-1,4-epoxy- 1<i>H</i>-1-benzazepine
C15H14FNOS
Acta Crystallographica Section C (2012) 68, 3 o131-o140
a=9.272(2)Å b=10.9142(13)Å c=12.963(2)Å
α=90.00° β=101.023(11)° γ=90.00°
7-fluoro-2-<i>exo</i>-(5-methylthiophen-2-yl)-2,3,4,5-tetrahydro-1,4-epoxy- 1<i>H</i>-1-benzazepine
C15H14FNOS
Acta Crystallographica Section C (2012) 68, 3 o131-o140
a=9.2106(16)Å b=10.906(2)Å c=13.4259(13)Å
α=90.00° β=106.086(12)° γ=90.00°
2-<i>exo</i>-(3-methylthiophen-2-yl)-7-trifluoromethoxy-2,3,4,5-tetrahydro- 1,4-epoxy-1<i>H</i>-1-benzazepine
C16H14F3NO2S
Acta Crystallographica Section C (2012) 68, 3 o131-o140
a=16.234(3)Å b=5.6113(5)Å c=16.665(3)Å
α=90.00° β=106.143(14)° γ=90.00°
<i>cis</i>-(2<i>RS</i>,4<i>SR</i>)-2-(thiophen-2-yl)-2,3,4,5-tetrahydro- 1<i>H</i>-1-benzazepin-4-ol
C14H15NOS
Acta Crystallographica Section C (2012) 68, 3 o126-o130
a=9.5677(6)Å b=9.8798(4)Å c=14.7183(11)Å
α=104.726(5)° β=104.033(6)° γ=103.273(4)°
<i>cis</i>-(2<i>RS</i>,4<i>SR</i>)-2-(5-methylthiophen-2-yl)-2,3,4,5-tetrahydro- 1<i>H</i>-1-benzazepin-4-ol
C15H17NOS
Acta Crystallographica Section C (2012) 68, 3 o126-o130
a=9.6764(5)Å b=10.6897(3)Å c=14.4433(5)Å
α=72.018(3)° β=89.108(3)° γ=72.494(3)°
(2<i>RS</i>,4<i>RS</i>)-7-Fluoro-2-(2-phenylethyl)-2,3,4,5-tetrahydro- 1<i>H</i>-1,4-epoxy-1-benzazepine
C18H18FNO
Acta Crystallographica Section C (2012) 68, 5 o195-o198
a=9.6285(4)Å b=11.2875(5)Å c=13.5147(6)Å
α=90.00° β=99.565(3)° γ=90.00°
Ethyl <i>N</i>-[4-(adamantan-1-ylamino)-2-amino-5-nitrosopyrimidin-6-yl]-3- aminopropionate
C19H28N6O3
Acta Crystallographica Section C (2012) 68, 5 o199-o203
a=11.6250(12)Å b=13.2225(11)Å c=13.0172(13)Å
α=90.00° β=101.920(8)° γ=90.00°
(2<i>RS</i>,4<i>RS</i>)-7-chloro-2-(2-phenylethyl)-2,3,4,5-tetrahydro- 1<i>H</i>-1,4-epoxy-1-benzazepine
C18H18ClNO
Acta Crystallographica Section C (2012) 68, 5 o195-o198
a=10.0891(10)Å b=10.981(2)Å c=13.7952(18)Å
α=90.00° β=92.771(11)° γ=90.00°
1,5-Bis(4-chlorophenyl)-3-(2-oxo-1,2-dihydroquinolin-3-yl)pentane-1,5-dione-- 1,5-bis(2-chlorophenyl)-3-(2-oxo-1,2-dihydroquinolin-3-yl)pentane-1,5-dione (84/16)
0.84(C26H19Cl2NO3),0.16(C26H19Cl2NO3)
Acta Crystallographica Section C (2012) 68, 6 o220-o225
a=22.268(4)Å b=22.268(4)Å c=18.398(5)Å
α=90.00° β=90.00° γ=90.00°
(9<i>RS</i>,10<i>RS</i>)-8,9-bis(4-chlorobenzyl)- 10-(2-oxo-1,2-dihydroquinolin-3-yl)-5,6,9,10-tetrahydrophenanthridine
C36H22Cl2N2O4
Acta Crystallographica Section C (2012) 68, 6 o220-o225
a=10.6771(19)Å b=11.5208(15)Å c=15.7275(13)Å
α=83.956(11)° β=72.795(13)° γ=68.204(14)°
Bis(6-amino-3-methyl-2-methylsulfanyl-4-oxopyrimidin-5-yl)methane
C13H18N6O2S2
Acta Crystallographica Section C (2013) 69, 9 1043-1046
a=19.862(6)Å b=7.4877(19)Å c=14.236(5)Å
α=90.00° β=133.61(2)° γ=90.00°
3,3'-[(1<i>RS</i>,3<i>SR</i>)-2-Oxocyclohexane-1,3-diyl]bis[(3<i>RS</i>,3'<i>SR</i>)-3-hydroxyindolin-2-one] dihydrate
C22H20N2O5,2(H2O)
Acta Crystallographica Section C (2013) 69, 9 1081-1084
a=8.3637(9)Å b=21.493(3)Å c=13.0968(14)Å
α=90.00° β=119.941(13)° γ=90.00°
(<i>E</i>)-3-<i>tert</i>-Butyl-4-(4-chlorobenzyl)-<i>N</i>-(4-chlorobenzylidene)-1-phenyl-1<i>H</i>-pyrazol-5-amine
C27H25Cl2N3
Acta Crystallographica Section C (2013) 69, 9 1039-1042
a=8.8820(5)Å b=10.1168(17)Å c=14.279(3)Å
α=69.627(13)° β=72.298(10)° γ=84.381(11)°
Ethyl 4''-bromo-4-fluoro-5'-hydroxy-1,1':3',1''-terphenyl-4'-carboxylate
C21H16BrFO3
Acta Crystallographica Section C (2015) 71, 7
a=10.0725(3)Å b=12.5793(3)Å c=14.9438(4)Å
α=104.3320(10)° β=92.4670(10)° γ=94.5650(10)°
4-Amino-5-chloro-2,6-dimethylpyridin-1-ium 5-chloro-2-hydroxybenzoate
C6H9ClN3,C7H4ClO3
Acta Crystallographica Section C (2017) 73, 11 862-868
a=24.7483(12)Å b=6.9525(3)Å c=18.1423(8)Å
α=90° β=111.500(3)° γ=90°
6-Methoxy-<i>N</i>^4^-{2-[(4-methylbenzylidene)amino]phenyl}-5-nitrosopyrimidine-2,4-diamine dimethyl sulfoxide monosolvate
C19H18N6O2,C2H6OS
Acta Crystallographica Section C (2018) 74, 6
a=10.801(5)Å b=17.301(8)Å c=11.777(7)Å
α=90° β=104.28(2)° γ=90°
Bis[4-amino-3,5-bis(pyridin-2-yl)-1,2,4-triazole-κ^2^<i>N</i>^1^,<i>N</i>^5^]bis(dicyanamido-κ<i>N</i>^1^)cadmium(II)
C28H20CdN18
Acta Crystallographica Section C (2017) 73, 9
a=8.7209(4)Å b=8.7949(4)Å c=10.3490(4)Å
α=91.966(2)° β=94.945(2)° γ=112.682(2)°
2-(4-Chlorophenyl)-<i>N</i>-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazol-4-yl)acetamide
C19H18ClN3O2
Acta Crystallographica Section C (2016) 72, 9
a=10.1018(4)Å b=10.6099(5)Å c=18.8129(11)Å
α=100.292(3)° β=91.881(3)° γ=116.873(2)°
2-Amino-5-nitroso-4,6-bis(3-pyridylmethoxy)pyrimidine
C16H14N6O3
Acta Crystallographica Section B (2004) 60, 1 76-89
a=6.881(2)Å b=9.140(3)Å c=24.4636(10)Å
α=90.00° β=90.00° γ=90.00°
Triphenylsilanol--4,4'-bipyridyl--water (2/1/2)
2(C18H16OSi),C10H8N2,2(H2O)
Acta Crystallographica Section B (2004) 60, 2 238-248
a=8.9058(4)Å b=13.9098(8)Å c=16.9083(8)Å
α=75.053(3)° β=88.509(3)° γ=86.951(3)°
Catena-poly[terephthalato-1,4,8,11- -tetraazacyclotetradecanenickel(II)] monohydrate
C18H28N4NiO4,H2O
Acta Crystallographica Section B (2002) 58, 1 78-93
a=16.2155(4)Å b=16.0404(6)Å c=8.8937(3)Å
α=90.00° β=118.4900(16)° γ=90.00°
Bis-(2-nitro-4-trifluoromethylphenyl) disulfide
C14H6F6N2O4S2
Acta Crystallographica Section B (2000) 56, 5 893-905
a=14.1617(5)Å b=5.3367(2)Å c=22.6233(10)Å
α=90.00° β=91.7376(13)° γ=90.00°
2,4-Dinitro-4'-methyldiphenyl disulfide
C13H10N2O4S2
Acta Crystallographica Section B (2000) 56, 5 893-905
a=10.1301(2)Å b=6.34740(10)Å c=11.1133(2)Å
α=90.00° β=106.644(8)° γ=90.00°
Meso-5,5,7,12,12,14-Hexamethyl-1,4,8,11-tetraazacyclotetradecane--5- hydroxyisophthalic acid--water (1/1/1)
C16H38N4,C8H4O5,H2O
Acta Crystallographica Section B (2000) 56, 6 1054-1062
a=11.8760(5)Å b=13.8395(6)Å c=15.8571(7)Å
α=90.00° β=90.00° γ=90.00°
1,4-Diazabicyclo[2.2.2]octane--ferrocene-1,1'-dicarboxylic acid (1/1)
C12H9FeO4,C6H13N2
Acta Crystallographica Section B (2002) 58, 5 786-802
a=7.4666(3)Å b=10.7846(5)Å c=11.3184(6)Å
α=104.897(2)° β=99.153(2)° γ=105.238(2)°
Dicyclohexylamine-ferrocene-1,1'-dicarboxylic acid--tetrahydrofuran (2/2/1)
2(C12H24N),2(C12H9FeO4),C4H8O
Acta Crystallographica Section B (2002) 58, 5 786-802
a=10.3588(2)Å b=11.9612(2)Å c=22.7731(5)Å
α=74.9690(8)° β=78.0660(8)° γ=64.4590(10)°
23-Nitrobenzylidene-2'-iodoaniline
C13H9IN2O2
Acta Crystallographica Section B (2002) 58, 5 864-876
a=7.9059(3)Å b=22.6230(7)Å c=7.6095(2)Å
α=90.00° β=113.7550(10)° γ=90.00°
4-Chlorodiphenyl sulfone
C12H9ClO2S
Acta Crystallographica Section B (2001) 57, 2 190-200
a=13.239(3)Å b=7.4521(15)Å c=11.737(2)Å
α=90.00° β=93.17(3)° γ=90.00°
Piperazine-ethane-1,2-diphosphonic acid (1/1)
C4H12N2,C2H6O6P2
Acta Crystallographica Section B (2001) 57, 1 95-102
a=7.3914(6)Å b=9.3343(7)Å c=9.3590(6)Å
α=90.00° β=107.291(4)° γ=90.00°
N-(4-Iodophenyl)-2-chloronicotinamide
C12H8ClIN2O
Acta Crystallographica Section B (2006) 62, 4 651-665
a=10.6597(2)Å b=25.9833(3)Å c=9.2044(6)Å
α=90.00° β=90.00° γ=90.00°
(E,E)-1,4-Bis(4-nitrophenyl)-2,3-diaza-1,3-butadiene
C14H10N4O4
Acta Crystallographica Section B (2006) 62, 4 666-675
a=3.7318(2)Å b=7.2442(3)Å c=23.9367(10)Å
α=90.00° β=94.053(2)° γ=90.00°
N-(4-chlorophenyl)pyrazinecarboxamide
C11H8ClN3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=5.8636(3)Å b=7.2433(5)Å c=13.1459(9)Å
α=100.854(3)° β=97.750(4)° γ=110.783(4)°
N-(2,6-difluorophenyl)pyrazinecarboxamide
C11H7F2N3O
Acta Crystallographica Section B (2008) 64, 1 84-100
a=9.8054(4)Å b=10.9355(5)Å c=19.4805(9)Å
α=90.00° β=103.474(2)° γ=90.00°
N-(2-methyl-5-nitrophenyl)pyrazinecarboxamide
C12H10N4O3
Acta Crystallographica Section B (2008) 64, 1 84-100
a=10.4767(5)Å b=14.5930(6)Å c=7.7136(3)Å
α=90.00° β=93.433(3)° γ=90.00°
2-Amino-6-benzyloxy-4-(N-phenylamino)-5-nitrosopyrimidine
C17H15N5O2
Acta Crystallographica Section B (2003) 59, 2 263-276
a=4.7622(3)Å b=5.8123(4)Å c=13.5635(11)Å
α=79.851(2)° β=87.346(2)° γ=89.692(5)°
(1R,3S)-Camphoric acid--piperazine (1/1)
C10H14O4,C4H12N2
Acta Crystallographica Section B (2003) 59, 1 118-131
a=19.1277(4)Å b=7.5743(6)Å c=10.6920(12)Å
α=90.00° β=90.00° γ=90.00°
2,4-Diiodo-3-nitroaniline
C6H4I2N2O2
Acta Crystallographica Section B (2002) 58, 4 701-709
a=7.6069(3)Å b=12.5917(4)Å c=10.2546(3)Å
α=90.00° β=106.6693(16)° γ=90.00°
Meso-5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazayclotetradecane- 3,5-dihydroxybenzoic acid (1/2)
C16H38N42,2(C7H5O4)
Acta Crystallographica Section B (2000) 56, 1 39-57
a=8.9162(13)Å b=11.8903(10)Å c=14.5229(18)Å
α=90.00° β=100.419(7)° γ=90.00°
6,6-diamino-α,α'-trehalose dihydrate
C12H24N2O9,2(H2O)
Acta Crystallographica Section B (2004) 60, 4 461-471
a=8.6093(2)Å b=8.6093(2)Å c=22.1566(8)Å
α=90.00° β=90.00° γ=90.00°
(4-(Pyrrolidin-1-yl)-1/H/-pyrazolo[3,4-/d/]pyrimidin-6-amine) ethanol hemisolvate hemihydrate
2(C9H12N6),C2H6O,H2O
Acta Crystallographica Section B (2008) 64, 5 610-622
a=7.9342(15)Å b=8.9219(19)Å c=16.767(3)Å
α=76.855(16)° β=83.505(14)° γ=88.003(17)°
C13H13ClN4O
C13H13ClN4O
Acta Crystallographica Section B (2008) 64, 5 596-609
a=8.1811(12)Å b=8.8325(10)Å c=9.3356(6)Å
α=81.844(9)° β=82.015(10)° γ=73.041(7)°
4,4'-Biphenol--1,4-diazabicyclo[2.2.2]octane (1/1).
C18H22N2O2
Acta Crystallographica Section B (1998) 54, 2 151-161
a=12.1510(9)Å b=6.3202(4)Å c=21.051(2)Å
α=90.00° β=98.875(10)° γ=90.00°
4-(2-Methoxyphenyl)piperazin-1-ium hydrogen maleate
C11H17N2O,C4H3O4
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=11.1076(6)Å b=11.1164(6)Å c=13.7649(7)Å
α=80.353(5)° β=78.353(5)° γ=74.406(5)°
4-(2-Methoxyphenyl)piperazin-1-ium hydrogen fumarate
C11H17N2O,0.5(C4H3O4),C1.14H0.86O1.14,C0.86H0.64O0.86)
Acta Crystallographica Section E (2020) 76, 11 1779-1793
a=7.8546(4)Å b=8.9626(6)Å c=11.2056(8)Å
α=79.043(5)° β=87.715(5)° γ=85.840(5)°
3-[5-(4-Chlorophenoxy)-3-methyl-1-phenyl-1<i>H</i>-pyrazol-4-yl]-1-[4-(prop-2-yn-1-yloxy)phenyl]prop-2-en-1-one
C28H21ClN2O3
Acta Crystallographica Section E (2020) 76, 5 683-691
a=8.9959(14)Å b=9.7380(15)Å c=13.637(2)Å
α=95.901(4)° β=94.122(4)° γ=95.959(4)°
1-(4-Azidophenyl)-3-[5-(2,4-dichlorophenoxy)-3-methyl-1-phenyl-1<i>H</i>-pyrazol-4-yl]prop-2-en-1-one
C25H17Cl2N5O2
Acta Crystallographica Section E (2020) 76, 5 683-691
a=28.1916(17)Å b=8.0537(5)Å c=22.0446(12)Å
α=90° β=109.0700(10)° γ=90°
Tris(5,5'-dimethyl-2,2'-bipyridine)iron(II) 1,1,3,3-tetracyano-2-ethoxypropenide tetrafluoridoborate
C36H36FeN62,C9H5N4O,BF4
Acta Crystallographica Section E (2018) 74, 12 1717-1726
a=11.5865(3)Å b=25.5914(5)Å c=14.4997(3)Å
α=90° β=104.641(3)° γ=90°
Tris(5,5'-dimethyl-2,2'-bipyridine)iron(II) 1,1,3,3-tetracyano-2-(ethylsufanyl)propenide tetrafluoridoborate
C36H36FeN62,C9H5N4S,BF4
Acta Crystallographica Section E (2018) 74, 12 1717-1726
a=11.6027(5)Å b=25.0774(10)Å c=14.7438(6)Å
α=90° β=104.211(2)° γ=90°
Bis(tri-2-pyridylamine)nickel(II) bis(perchlorate)
C30H24N8Ni2,2(ClO4)
Acta Crystallographica Section E (2018) 74, 5 668-672
a=8.360(4)Å b=17.570(8)Å c=11.165(5)Å
α=90° β=99.542(5)° γ=90°
Trihexyphenidylium 3,5-dinitrobenzoate
C20H32NO,C7H3N2O6
Acta Crystallographica Section E (2019) 75, 2 292-298
a=11.2743(12)Å b=11.2898(12)Å c=12.6478(13)Å
α=111.9230(10)° β=114.3250(10)° γ=95.9030(10)°
(2<i>E</i>)-1-(5-Bromothiophen-2-yl)-3-(4-ethoxyphenyl)prop-2-en-1-one
C15H13BrO2S
Acta Crystallographica Section E (2015) 71, 9 1093-1099
a=16.5498(7)Å b=7.5069(4)Å c=11.1574(5)Å
α=90° β=92.618(4)° γ=90°
Furan-2,5-diylbis(diphenylmethanol)-dimethylfsulfoxide (2/1)
C30H24O3,0.5C2H6OS
Acta Crystallographica Section C (1996) 52, 8 2009-2014
a=8.802(3)Å b=11.707(3)Å c=13.162(4)Å
α=80.17(1)° β=72.07(1)° γ=84.19(1)°
1-Ferrocenyl-2,2-methylpropan-1-ol
C15H20FeO
Acta Crystallographica Section C (1994) 50, 6 857-861
a=5.9826(9)Å b=10.1528(7)Å c=21.785(3)Å
α=90.0° β=90.0° γ=90.0°
N,N'-Dithiodiphthalimide
C16H8N2O4S2
Acta Crystallographica Section C (2001) 57, 6 742-746
a=14.3782(13)Å b=16.0723(14)Å c=7.7910(7)Å
α=90° β=93.256(2)° γ=90°
N-(3-Nitrophenyl)phthalimide
C14H8N2O4
Acta Crystallographica Section C (2004) 60, 1 o24-o27
a=6.6650(5)Å b=3.6962(3)Å c=23.639(2)Å
α=90° β=95.208(3)° γ=90°
2,6-Dichlorobenzohydrazide
C7H6Cl2N2O
Acta Crystallographica Section C (2006) 62, 10 o618-o624
a=7.5511(2)Å b=14.4834(4)Å c=8.3097(3)Å
α=90.00° β=110.485(2)° γ=90.00°
3,5-Bis(4-fluorophenyl)-1-phenyl-1<i>H</i>-pyrazole
C21H14F2N2
Acta Crystallographica Section C (2014) 70, 9
a=31.729(2)Å b=10.4118(7)Å c=10.1697(6)Å
α=90° β=97.700(7)° γ=90°
Tetraaquaberyllium 4-oxo-4H-pyran-2,6-dicarboxylate
BeH8O42,C7H2O62
Acta Crystallographica Section C (2007) 63, 5 m207-m215
a=5.4331(2)Å b=10.6173(4)Å c=19.1890(5)Å
α=90.00° β=97.771(2)° γ=90.00°
Hexamethylenetetramine--ferrocene-1,1'-dicarboxylic acid (1/1)
C12H10FeO4,C6H12N4
Acta Crystallographica Section C (2003) 59, 7 m271-m274
a=10.0096(4)Å b=7.1396(2)Å c=24.2841(8)Å
α=90.00° β=90.00° γ=90.00°
4,4'-Trimethylenedipyridinium bis[carboxymethylphosphonate(1-)]
C13H16N22,2C2H4O5P1
Acta Crystallographica Section C (2003) 59, 8 o464-o466
a=27.366(2)Å b=32.347(2)Å c=4.8818(3)Å
α=90.00° β=90.00° γ=90.00°
2,3-Bis[(4-methylphenyl)sulfanyl]-4H-1-benzothiopyran-4-one 1,1-dioxide
C23H18O3S3
Acta Crystallographica Section C (2004) 60, 5 o350-o352
a=9.6349(3)Å b=22.5791(7)Å c=9.1895(4)Å
α=90.00° β=91.253(2)° γ=90.00°
2-Iodo-N-(4-nitrophenyl)benzamide
C13H9IN2O3
Acta Crystallographica Section C (2005) 61, 7 o450-o451
a=10.3792(4)Å b=13.6412(6)Å c=9.8265(4)Å
α=90.00° β=107.3830(11)° γ=90.00°